Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AZD0305 |
Synonyms | |
Therapy Description |
Limited information is currently available on AZD0305 (Dec 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AZD0305 | AZD-0305|AZD 0305 | Limited information is currently available on AZD0305 (Dec 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06106945 | Phase Ib/II | AZD0305 | A Phase I/II Study of AZD0305 for Relapsed/Refractory Multiple Myeloma | Recruiting | USA | FRA | ESP | DEU | CAN | AUS | 2 |